At the peak of the COVID-19 pandemic, many pharmacists were faced with questions about treatment for which they felt they had no evidence-based answers.

With better treatments than ever, why don’t patients with respiratory conditions show better outcomes as well?

The PSA’s WA Pharmacist of the Year Richard Smirk serves as the Clinical Advisor Pharmacy at the Australian Health Practitioner Regulation Agency (Ahpra) in Perth.

In the lead up to World Pharmacists Day (WPD) on 25 September, pharmacists share how they rose to the occasion throughout the COVID-19 pandemic, gaining increased recognition along the way. 

As the detail of the Seventh Community Pharmacy Agreement is worked out, five subject matter experts share their thoughts so far. Pharmacy in Australia...

Neuropathic pain is defined as ‘pain caused by a lesion or disease of the somatosensory nervous system’.1 It is associated with impaired quality of...